Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Month: July 2023
Talis Biomedical Announces 1-for-15 Reverse Stock Split
REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
Talis Biomedical Announces 1-for-15 Reverse Stock Split
REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
Positive Aggregate Safety Data From Vafidemstat’s Ongoing Phase IIb PORTICO Trial in Borderline Personality Disorder
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on…
Positive Aggregate Safety Data From Vafidemstat’s Ongoing Phase IIb PORTICO Trial in Borderline Personality Disorder
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on…
Ayala Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA Regarding AL102 for the Treatment of Desmoid Tumors
Company confirms FDA agreement on key elements of the Phase 3 segment of ongoing RINGSIDE…
Spectral Medical Announces the Opening of Three Additional Tigris Clinical Trial Sites
University of Alabama enrolls patient 65 after second day of opening for enrollment TORONTO, July…
Ayala Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA Regarding AL102 for the Treatment of Desmoid Tumors
Company confirms FDA agreement on key elements of the Phase 3 segment of ongoing RINGSIDE…
Spectral Medical Announces the Opening of Three Additional Tigris Clinical Trial Sites
University of Alabama enrolls patient 65 after second day of opening for enrollment TORONTO, July…
Cognition Therapeutics and the Alzheimer’s Clinical Trials Consortium Initiate First Clinical Site in the Phase 2 START Study in Early Alzheimer’s Disease
NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced that…
Cognition Therapeutics and the Alzheimer’s Clinical Trials Consortium Initiate First Clinical Site in the Phase 2 START Study in Early Alzheimer’s Disease
NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced that…
COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital
LONDON, July 05, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company…
COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital
LONDON, July 05, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company…
FreshBooks Invites Accounting Professionals to New Accountant Hub: A Client Support Platform Designed For Accountants, By Accountants
Toronto, July 05, 2023 (GLOBE NEWSWIRE) — FreshBooks, a leading cloud-based accounting software platform built…
FreshBooks Invites Accounting Professionals to New Accountant Hub: A Client Support Platform Designed For Accountants, By Accountants
Toronto, July 05, 2023 (GLOBE NEWSWIRE) — FreshBooks, a leading cloud-based accounting software platform built…
PingCAP Launches TiDB Serverless, a Cutting-Edge Solution to Optimize Application Development and Performance
TiDB Serverless is a fully-managed, autonomous DBaaS offering with auto-scaling, cluster provisioning and usage-based pricing…
PingCAP Launches TiDB Serverless, a Cutting-Edge Solution to Optimize Application Development and Performance
TiDB Serverless is a fully-managed, autonomous DBaaS offering with auto-scaling, cluster provisioning and usage-based pricing…
Micromem Received Purchase Order
Toronto, Ontario and New York, New York–(Newsfile Corp. – July 5, 2023) – Micromem Technologies…
Micromem Received Purchase Order
Toronto, Ontario and New York, New York–(Newsfile Corp. – July 5, 2023) – Micromem Technologies…
Sequans Monarch 2 GM02S NEKTAR EVKs Now Available on Verizon ThingSpace Marketplace
Paris, France–(Newsfile Corp. – July 5, 2023) – Now Available for purchase on Verizon’s ThingSpace…